Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Vascular Access Complication: later-stage trial registry

3 of 7 indexed Vascular Access Complication trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Vascular Access Complication: 7 US clinical trials tracked, 3 recruiting.

Vascular Access Complication is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 2 of these trials.

Enrollment posture brief

Registry condition vascular-access-complication

OPEN 3 | RECR 43% | LATE 2 | EARLY 1 | RANK #2497 | SPON 2

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Vascular Access Complica (th…43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Vascular Access Complication

Vascular Access Complication lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Vascular Access Complication on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Vascular Access Complication is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Vascular Access Complication research.

    Mayo Clinic accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Vascular Access Complication enrolment sits around 128 participants.

    Median target enrolment is 128 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.

  4. Vascular Access Complication research is mostly interventional.

    7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 32

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 2

Named interventions

Most-linked intervention names on Vascular Access Complication records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sirolimus-eluting Collagen Implant (SeCI) Device
1 trials
AV Fistula Surgery Procedure
1 trials
Radial access versus femoral access for coronary angiography and intervention Procedure
1 trials
Ultrasound probe Device
1 trials
Butterfly iQ+ ultrasound probe Device
1 trials
Two Applications of Adipose Derived Mesenchymal Stem Cells (AMSC) Biological
1 trials
Single Application of Adipose Derived Mesenchymal Stem Cells (AMSC) Biological
1 trials
State-of-the-art femoral access with 21 gauge needle Procedure
1 trials

US sites by state

Facility locations filed on Vascular Access Complication trials. A trial with sites in several states counts in each.

Minnesota 4 trials
California 4 trials
Texas 2 trials
South Carolina 2 trials
New York 2 trials
Massachusetts 2 trials
Florida 2 trials
Arizona 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Vascular Access Complication page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Vascular Access Complication trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mayo Clinic sponsors the most Vascular Access Complication trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vascular Access Complication condition card totals 7 registered trials; most-linked intervention Sirolimus-eluting Collagen Implant (SeCI); top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.